Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

03/02/2021 04:30

Feb 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             57.08               70.18            77.20    
                 (-18.7 pct)         (-3.3 pct)       (-13.5 pct) 
  Operating         14.95               22.43            18.10    
                 (-33.4 pct)         (+12.7 pct)      (-31.7 pct) 
  Recurring         15.35               22.83            18.50    
                 (-32.8 pct)         (+12.7 pct)      (-31.3 pct) 
  Net               10.93               15.55            13.40    
                 (-29.7 pct)         (+9.2 pct)       (-30.8 pct) 
  EPS            282.69 yen          396.67 yen       349.70 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T